Search
-
Pandemic takes heavy toll on Greek workers, study finds
EconomyFeaturespercent of employees had a net monthly income of 200 euros. This rose to 12 percent in Q2 2020. During
5% -
Building permits drops by 3.3 pct in Aug, up by 13.7 pct in 8-month period
EconomyMacroeconomyBuilding permits fell by 3.3 percent year-on-year (YoY) in August compared to a rise of 12 percent in July, Hellenic Statistical Authority (ELSTAT) data released on Thursday showed. The total number of permits came to 1,294. The corresponding surface area fell by 8.7 percent while volume decreased
5% -
Extensive Covid-19 impact and slow recovery seen by most business sectors, research shows
EconomyMacroeconomyby the IT - telecommunications sector (12 percent). Just under 31 percent of companies had applied for reduced rent programmes
5% -
Greece persistently bottom of the list for EU gender equality
Societybanks versus 22.1 percent in the EU. Women make up 12 percent of members of the boards of research
5% -
Eurobank net results show loss of 1.08 bln in 9M
EconomyBankingin Q3 compared to 12 percent in Q2. NPL coverage ratio came to 79.7 percent from 68.6 percent in 9M
5% -
Newsletter 275 -27/11/2020
investments is 4 billion. Athens wants to use the 12.6 billion euros of loans to mobilise 12 billion euros
5% -
Apartment prices rise by 3.2 pct in Q3
EconomyMacroeconomyof 12 percent in July according to the Hellenic Statistical Authority (ELSTAT). The total number
5% -
Updated IMF DSA sees Greek debt as sustainable in medium-term, risks over long-term
EconomyMacroeconomy5 billion in 2020 and 12 billion over the 2022-25 period, which includes the 15.7 billion
5% -
GDP grows by 2.3 pct QoQ in Q3 and drops by 11.7 pct YoY as services exports crash
EconomyMacroeconomyto the corresponding quarter last year, private consumption rose by 1 percent YoY in Q3 after having fallen by 12
5% -
The risk of losing control before help arrives
AgoraVaccines for Sars-CoV-2, the virus that causes Covid-19, produced by the pharmaceutical companies Pfizer/BioNTech and Moderna are expected to be approved by the European Medicines Agency (EMA), the regulator of the European Union (EU), between December 29, 2020 and January 12, 2021, at the latest
5%